American Express Gets Dueling Calls From BofA and Barclays: Which Side Is Right?

American Express‘s (NYSE:AXP | AXP Price Prediction) Q1 2026 earnings beat drew a split verdict from Wall Street. Bank of America reiterated its Buy rating and raised its price target to $387 from $381, while Barclays kept an Equal Weight rating and trimmed its price target to $322 from $323.

The disagreement cuts to the heart of the premium consumer debate. American Express posted EPS of $4.28 and revenue of $18.907 billion, both topping estimates. AXP stock trades at $312.82, down 13% year to date.

For long-term American Express investors, the dueling calls crystallize a real choice: trust the durability of premium spending, or brace for credit normalization. The answer shapes whether American Express stock deserves accumulation on weakness or a lighter position size.

The Analyst’s Case

Bank of America’s bullish stance leans on what it called “strong” Q1 results that beat on both top and bottom line. The firm argues the print is consistent with its view that “premium consumers are doing well”, underpinning its higher American Express price target.

Barclays acknowledges the quarter’s operational strength and highlighted that billed business growth accelerated across consumer, commercial, and international, driving revenue growth “towards the aspirational target”. Yet Barclays held at Equal Weight, implying the good news is largely priced into AXP shares.

Both firms agree on the top line. American Express delivered billed business of $428 billion, up 10% year over year and 9% FX-adjusted Card Member spending growth, the highest quarterly rate in three years. The debate centers on valuation and demand durability.

Company Snapshot

American Express is a global premium card issuer and closed-loop payments network with a market capitalization of $228.57 billion. Its membership model generates recurring card fees alongside transaction and lending revenue.

American Express’s Q1 2026 net income came in at $2.971 billion, up roughly 15% year over year, while credit held firm with a net write-off rate of 2%, down from 2.1%. Management reaffirmed full-year 2026 guidance for 9% to 10% revenue growth and EPS of $17.30 to $17.90.

Why the Move Matters Now

American Express shares trade at a trailing P/E ratio of 20x and a forward P/E ratio of 18x, with an analyst consensus target of $359.02. BofA’s $387 sits at the bullish end while Barclays’ $322 sits below the current AXP stock price.

The macro backdrop complicates the read. University of Michigan consumer sentiment fell to 53.3 in March, a pessimistic reading, while unemployment sits at 4%. For broader context on the payments landscape shaping American Express, see our recent credit card stocks outlook.

What It Means for Your Portfolio

The bull case for AXP stock rests on premium consumer resilience, international expansion, and pricing power on card fees. American Express has posted 30-plus consecutive quarters of double-digit net card fee growth, and the U.S. Platinum refresh doubled new account acquisitions versus pre-refresh levels.

The bear case centers on credit normalization, rising competition from Capital One (NYSE:COF) and JPMorgan (NYSE:JPM) premium cards, and recession risk if consumer sentiment slides. A 15% year-to-date decline in American Express stock already reflects some caution.

For investors, the framework is straightforward. If affluent spending holds up through a soft patch, BofA’s thesis may prove right and current weakness could offer an attractive entry. However, if consumer credit cracks and surcharging or rate-cap regulation tightens, Barclays’ caution is the safer read and trimming American Express stock exposure would be prudent.